Savara to present trial data at 2026 respiratory disease conference

April 14, 2026 8:05 AM

Savara Inc. (NASDAQ: SVRA) will present new data from its Phase 3 IMPALA-2 clinical trial at the American Thoracic Society ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found